Meet a Few of the Companies
Succeeding with Veeva eCOA
Alcon: Expanding the Success of the Clinical Platform
Enabled to self-build, with 10 studies live in 6 months.
Why choose Veeva eCOA
- Increase study autonomy
- Optimize efficiencies
- Increase data quality
Results so far:
Autonomy
Ability to self-build gives teams control over the study processes and timelines.
Highly scalable
Optimized efficiencies and reusability have significantly shortened build times.
Data quality
Data is accurate, complete, and attributable.
Platform efficiencies
Seamless data flow across the Veeva Clinical Platform enables data aggregation, cleaning, and transformation alongside other data sources.
“With Veeva eCOA, our clinical data team can rapidly self-build studies to meet important IRB and FPI milestones while moving fast. This helps us launch eCOA quickly while improving data quality, access, and traceability.”
UCB: Supporting Patient Choice with a Connected Platform
UCB sought a sustainable solution to collect patient reported outcomes and accelerate while maintaining quality.
Watch this video to find out how Veeva eCOA enables UCB to provide patients’ optionality, engage sites, and increase efficiencies through end-to-end data flow.
“The value of Veeva Clinical Platform is the data flow, the connected workflows, and end-to-end insights throughout the whole process.”
200+ Validated Instruments Supported by Veeva eCOA
The Veeva eCOA Library includes 200+ fully reusable instruments, enabling faster study setup and improved data quality. With a dedicated librarian to manage the library and collaborate with authors and copyright holders, sponsors gain access to validated, pre-approved assessments that streamline deployment and minimize delays
View the full list of instruments in the Veeva eCOA Library.
Members of the Electronic Clinical Outcome Assessment (eCOA) Consortium
Veeva has joined the Critical Path Institute (C-Path)’s eCOA Consortium to collaborate with industry leaders on improving eCOA standards for all.
The consortium provides scientific leadership and best practice recommendations for the use of electronic data capture technologies and services in clinical trials.
“C-Path’s eCOA Consortium is the only dedicated pre-competitive alliance of eCOA/DHT technology and allied service providers in existence. Membership of the eCOA Consortium conveys a clear commitment to driving the effective use of eCOA & DHT systems in clinical research. I’m absolutely delighted to have Veeva amongst our membership to help the eCOA Consortium and the industry as a whole move forward.”
